The “backdoor” [Bioanalytics]

posted by Helmut Homepage – Vienna, Austria, 2017-12-16 14:23 (1927 d 06:36 ago) – Posting: # 18065
Views: 2,432

Hi ElMaestro,

❝ what is the current regulatory sentiment towards the need for chiral assays?

Duno. Agree with your other statements. See also this post. At a conference in 2014 another regulator told me that this paragraph is a kind of “loophole”:

“If we don’t like [sic!] the study and find no other reason to reject it, we can use the backdoor…”

Note also that all product-specific guidances published so far don’t recommend a chiral assay.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,553 posts in 4,724 threads, 1,606 registered users;
12 visitors (0 registered, 12 guests [including 6 identified bots]).
Forum time: 21:59 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz